b-AP15 and PtPT, as inhibitors of USP14 and UCHL5, have been demonstrated that they can induce apoptosis in myeloma, triple negative breast cancer (TNBC) cell lines23 and prostate cancer cells14. Here, PTPN2 is linked to prostate carcinoma.